Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$402.4 - $446.42 $5,633 - $6,249
-14 Reduced 43.75%
18 $7,000
Q2 2023

Aug 09, 2023

SELL
$354.01 - $427.31 $2,478 - $2,991
-7 Reduced 17.95%
32 $13,000
Q1 2023

May 10, 2023

BUY
$335.35 - $386.06 $3,353 - $3,860
10 Added 34.48%
39 $13,000
Q4 2022

Feb 13, 2023

SELL
$346.68 - $397.58 $2,773 - $3,180
-8 Reduced 21.62%
29 $10,000
Q3 2022

Nov 10, 2022

BUY
$321.25 - $373.84 $2,248 - $2,616
7 Added 23.33%
37 $13,000
Q1 2022

May 11, 2022

BUY
$244.61 - $310.48 $7,338 - $9,314
30 New
30 $9,000
Q3 2021

Nov 12, 2021

SELL
$188.42 - $208.66 $942 - $1,043
-5 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$184.89 - $202.68 $3,328 - $3,648
-18 Reduced 78.26%
5 $1,000
Q1 2021

May 14, 2021

BUY
$169.52 - $196.53 $3,898 - $4,520
23 New
23 $4,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $74.7B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Rock Creek Group, LP Portfolio

Follow Rock Creek Group, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Creek Group, LP with notifications on news.